Ocugen Beats Investor Suit Over Financial Controls
By Sydney Price · July 29, 2025, 9:48 PM EDT
Biopharmaceutical company Ocugen Inc. on Tuesday won permanent dismissal from an investor's class action accusing it of concealing weak financial controls that led to it refiling accounting statements for several periods,...
To view the full article, register now.